Biz in Saigon

Ho Chi Minh City Establishes Venture Capital Fund to Fuel Innovation and Startups

The Ho Chi Minh City (HCMC) People’s Committee has officially approved a proposal to establish the HCMC Venture Capital Fund (HVCF). The fund is designed to provide additional financial resources for innovative startups, foster scientific and technological development, [...]

Read more

Latest News

MiniLuxe Partners with 2026 NCAA Champion Kiki Rice as its Inaugural Brand Ambassador

The WNBA Draftee joins MiniLuxe as brand ambassador and investor, signaling a shift toward partnerships [...]

Royalton Hotels & Resorts Among Mexico’s Top Three Hospitality Employers

CANCÚN, Mexico, April 13, 2026 (GLOBE NEWSWIRE) — As Mexico continues to strengthen its position [...]

Biomerica Reports Third Quarter Fiscal 2026 Financial Results

IRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or the [...]

Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support

A 2026 Informational Overview of CleanEye Vision Care Capsules, Retina Support Ingredient Categories, Lutein and [...]

AIM ImmunoTech Provides Routine Update on Annual Filings

OCALA, Fla., April 13, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or [...]

XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

• VB4-P5 – novel new chemical entity with potential to address significant unmet need in [...]

Most Read

Don’t miss it

ONL Therapeutics Closes $65 Million in Oversubscribed Series D Financing

Funds will advance the development of ONL1204 Ophthalmic Solution with the initiation of a Phase [...]

Habit Burger & Grill Unveils Its New Sirloin Steak Sandwich

Habit elevates the classic steak sandwich with premium sirloin and savory flavor IRVINE, Calif., Sept. [...]

Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.

Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement: The Capital Group [...]

TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Favorable safety and tolerability profile with no Grade 3 or greater treatment-related adverse events Company [...]

Scientists Discuss the Recent CancerVax Breakthrough

The Company’s scientific team describes how they successfully disguised cancer cells and tricked immune cells [...]

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN) is [...]